tetano
Editor, Senior Moderator
Biomed Pharmacother
. 2023 Aug 17;166:115321.
doi: 10.1016/j.biopha.2023.115321. Online ahead of print. Role of SARS-COV-2 and ACE2 in the pathophysiology of peripheral vascular diseases
Hamid Tanzadehpanah[SUP] 1 [/SUP], Elham Lotfian[SUP] 2 [/SUP], Amir Avan[SUP] 3 [/SUP], Sahar Saki[SUP] 4 [/SUP], Sima Nobari[SUP] 4 [/SUP], Roghaye Mahmoodian[SUP] 4 [/SUP], Mohsen Sheykhhasan[SUP] 5 [/SUP], Mohamad Hosein Shafiee Froutagh[SUP] 6 [/SUP], Farzaneh Ghotbani[SUP] 7 [/SUP], Raoufeh Jamshidi[SUP] 7 [/SUP], Hanie Mahaki[SUP] 8 [/SUP]
Affiliations
The occurrence of a novel coronavirus known as severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), created a serious challenge worldwide. SARS-CoV-2 has high infectivity, the ability to be transmitted even during the asymptomatic phase, and relatively low virulence, which has resulted in rapid transmission. SARS-CoV-2 can invade epithelial cells, hence, many patients infected with SARS-CoV-2 have suffered from vascular diseases (VDs) in addition to pulmonary manifestations. Accordingly, SARS-CoV-2 may can worsen the clinical condition of the patients with pre-existing VDs. Endothelial cells express angiotensin-converting enzyme 2 (ACE2). ACE2 is a biological enzyme that converts angiotensin (Ang)- 2 to Ang-(1-7). SARS-CoV-2 uses ACE2 as a cell receptor for viral entry. Thus, the SARS-CoV-2 virus promotes downregulation of ACE2, Ang-(1-7), and anti-inflammatory cytokines, as well as, an increase in Ang-2, resulting in pro-inflammatory cytokines. SARS-CoV-2 infection can cause hypertension, and endothelial damage, which can lead to intravascular thrombosis. In this review, we have concentrated on the effect of SARS-CoV-2 in peripheral vascular diseases (PVDs) and ACE2 as an enzyme in Renin-angiotensin aldosterone system (RAAS). A comprehensive search was performed on PubMed, Google Scholar, Scopus, using related keywords. Articles focusing on ("SARS-CoV-2", OR "COVID-19"), AND ("Vascular disease", OR "Peripheral vascular disease", OR interested disease name) with regard to MeSH terms, were selected. According to the studies, it is supposed that vascular diseases may increase susceptibility to severe SARS-CoV-2 infection due to increased thrombotic burden and endothelial dysfunction. Understanding SARS-CoV-2 infection mechanism and vascular system pathogenesis is crucial for effective management and treatment in pre-existing vascular diseases.
Keywords: Angiotensin-converting enzyme (ACE); COVID-19; Peripheral vascular disease; SARS-CoV-2.
. 2023 Aug 17;166:115321.
doi: 10.1016/j.biopha.2023.115321. Online ahead of print. Role of SARS-COV-2 and ACE2 in the pathophysiology of peripheral vascular diseases
Hamid Tanzadehpanah[SUP] 1 [/SUP], Elham Lotfian[SUP] 2 [/SUP], Amir Avan[SUP] 3 [/SUP], Sahar Saki[SUP] 4 [/SUP], Sima Nobari[SUP] 4 [/SUP], Roghaye Mahmoodian[SUP] 4 [/SUP], Mohsen Sheykhhasan[SUP] 5 [/SUP], Mohamad Hosein Shafiee Froutagh[SUP] 6 [/SUP], Farzaneh Ghotbani[SUP] 7 [/SUP], Raoufeh Jamshidi[SUP] 7 [/SUP], Hanie Mahaki[SUP] 8 [/SUP]
Affiliations
- PMID: 37597321
- DOI: 10.1016/j.biopha.2023.115321
The occurrence of a novel coronavirus known as severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), created a serious challenge worldwide. SARS-CoV-2 has high infectivity, the ability to be transmitted even during the asymptomatic phase, and relatively low virulence, which has resulted in rapid transmission. SARS-CoV-2 can invade epithelial cells, hence, many patients infected with SARS-CoV-2 have suffered from vascular diseases (VDs) in addition to pulmonary manifestations. Accordingly, SARS-CoV-2 may can worsen the clinical condition of the patients with pre-existing VDs. Endothelial cells express angiotensin-converting enzyme 2 (ACE2). ACE2 is a biological enzyme that converts angiotensin (Ang)- 2 to Ang-(1-7). SARS-CoV-2 uses ACE2 as a cell receptor for viral entry. Thus, the SARS-CoV-2 virus promotes downregulation of ACE2, Ang-(1-7), and anti-inflammatory cytokines, as well as, an increase in Ang-2, resulting in pro-inflammatory cytokines. SARS-CoV-2 infection can cause hypertension, and endothelial damage, which can lead to intravascular thrombosis. In this review, we have concentrated on the effect of SARS-CoV-2 in peripheral vascular diseases (PVDs) and ACE2 as an enzyme in Renin-angiotensin aldosterone system (RAAS). A comprehensive search was performed on PubMed, Google Scholar, Scopus, using related keywords. Articles focusing on ("SARS-CoV-2", OR "COVID-19"), AND ("Vascular disease", OR "Peripheral vascular disease", OR interested disease name) with regard to MeSH terms, were selected. According to the studies, it is supposed that vascular diseases may increase susceptibility to severe SARS-CoV-2 infection due to increased thrombotic burden and endothelial dysfunction. Understanding SARS-CoV-2 infection mechanism and vascular system pathogenesis is crucial for effective management and treatment in pre-existing vascular diseases.
Keywords: Angiotensin-converting enzyme (ACE); COVID-19; Peripheral vascular disease; SARS-CoV-2.